What is pyelonephritis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Pyelonephritis: Definition and Clinical Overview

Pyelonephritis is a severe urinary tract infection characterized by inflammation of the renal pelvis and kidney parenchyma, which has the potential to cause sepsis, shock, and death if left untreated. 1

Epidemiology

  • Approximately 250,000 cases occur annually in the United States, resulting in more than 100,000 hospitalizations 2
  • The annual incidence is estimated at 459,000 to 1,128,000 cases in the United States and 10.5 to 25.9 million cases globally 1
  • Pyelonephritis occurs more frequently in young women but affects older men and women at similar rates 3

Etiology

  • Escherichia coli is the predominant causative organism:
    • Accounts for >90% of cases in young healthy women 1, 4
    • Responsible for 70-90% of all pyelonephritis infections 3
  • In men, elderly women, and urologically compromised patients, other pathogens are more common:
    • Less-virulent E. coli strains 1, 4
    • Gram-negative bacilli (Klebsiella, Pseudomonas, Proteus) 4, 3
    • Gram-positive organisms (Enterococcus, Staphylococcus) 5, 3
    • Candida (especially in immunocompromised patients) 4, 6

Pathophysiology

  • Most commonly occurs through ascending infection from the lower urinary tract 3
  • Rarely results from hematogenous seeding of the kidney 6, 3
  • The inflammatory process leads to the formation of microabscesses that may coalesce into larger abscesses 4
  • In severe cases, microabscesses can coalesce to form acute renal abscesses that may rupture into the perinephric space 1
  • Infection may be confined to an obstructed collecting system causing pyonephrosis (accumulation of purulent material in the upper urinary collecting system) 1

Risk Factors

  • Factors that disrupt normal urinary flow:
    • Vesicoureteral reflux 1, 5
    • Congenital urinary tract anomalies 1, 5
    • Altered bladder function 1, 5
    • Pregnancy 1, 5
    • Renal calculi 1, 5, 3
    • Mechanical obstruction 1, 5
  • Host factors:
    • Diabetes mellitus 1, 5, 3
    • Genetic predisposition 1, 5
    • Personal or maternal history of UTIs 1, 5
    • Postmenopausal status with atrophic vaginitis 5
  • Behavioral factors:
    • Sexual activity and new sexual partner 1, 3
    • Spermicide exposure 1, 5

Clinical Presentation

  • Systemic inflammation signs:
    • Fever (though may be absent early in illness) 1, 4, 7
    • Chills and fatigue 1
  • Flank pain and tenderness (nearly universal in acute pyelonephritis) 1, 4, 7
  • Bladder inflammation symptoms (in approximately 80% of patients):
    • Urgency 1
    • Dysuria 1
    • Urinary frequency 1
  • Clinical presentation can range from mild flank pain with low-grade or no fever to septic shock 1
  • Up to 20% of patients may lack typical bladder symptoms 1, 4

Diagnosis

  • Clinical diagnosis based on compatible history and physical examination 7
  • Urinalysis showing pyuria and/or bacteriuria supports the diagnosis 1
  • Urine culture yielding >10,000 colony-forming units of a uropathogen per milliliter is the fundamental confirmatory test 1, 8
  • Blood cultures may assist with diagnosis but should be reserved for patients with uncertain diagnosis, immunocompromised patients, or those suspected of having hematogenous infections 2

Complications

  • Acute kidney injury 4
  • Renal scarring (occurs in approximately 15% of patients after first episode) 4
  • Papillary necrosis 3
  • Renal or perinephric abscess 3
  • Emphysematous pyelonephritis 3
  • Long-term complications from renal scarring may include hypertension and chronic renal failure 4

Treatment

  • Uncomplicated pyelonephritis in men and women:
    • Short-course therapy with fluoroquinolones (5-7 days) or trimethoprim-sulfamethoxazole (14 days) based on antibiotic susceptibility 1
    • When local resistance to chosen oral antibiotic likely exceeds 10%, one dose of a long-acting broad-spectrum parenteral antibiotic should be given while awaiting susceptibility data 8
  • Hospitalization indications:
    • Complicated infections 2
    • Sepsis 2
    • Persistent vomiting 2
    • Failed outpatient treatment 2
    • Extremes of age 2
    • Pregnancy (due to significantly elevated risk of severe complications) 8

Clinical Pearls and Pitfalls

  • Not all patients with pyelonephritis present with fever - absence of fever does not exclude the diagnosis 5
  • Absence of flank pain should raise suspicion of an alternative diagnosis 7
  • Imaging studies are not necessary in uncomplicated cases but should be considered if there is no improvement in symptoms or if symptoms recur after initial improvement 7, 8
  • Treatment failure may be caused by resistant organisms, underlying anatomic/functional abnormalities, or immunosuppressed states 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Pathophysiology of Pyelonephritis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Bilateral Pyelonephritis Causes and Risk Factors

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Management of pyelonephritis and upper urinary tract infections.

The Urologic clinics of North America, 1999

Research

Diagnosis and treatment of acute pyelonephritis in women.

American family physician, 2011

Research

Acute Pyelonephritis in Adults: Rapid Evidence Review.

American family physician, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.